What is Lifemd, Inc.'s earnings per share (EPS)?

Lifemd, Inc. (LFMDP) reported diluted earnings per share of $0.25 for fiscal year 2025. This represents a 141.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lifemd, Inc. Financials

LFMDP

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Lifemd, Inc. (LFMDP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Lifemd, Inc. has an operating margin of -4.0%, meaning the company retains $-4 of operating profit per $100 of revenue. This below-average margin results in a low score of 13/100, suggesting thin profitability after operating expenses. This is up from -13.2% the prior year.

Growth

Lifemd, Inc.'s revenue surged 25.3% year-over-year to $194.1M, reflecting rapid business expansion. This strong growth earns a score of 76/100.

Leverage

Lifemd, Inc. has a moderate D/E ratio of 2.04. This balance of debt and equity financing earns a leverage score of 60/100.

Liquidity

Lifemd, Inc.'s current ratio of 1.25 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 20/100, which could limit financial flexibility.

Cash Flow

Lifemd, Inc. has a free cash flow margin of 3.3%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

100

Lifemd, Inc. earns a strong 62.0% return on equity (ROE), meaning it generates $62 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.

Piotroski F-Score Neutral

5/9

Lifemd, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

0.58x

For every $1 of reported earnings, Lifemd, Inc. generates $0.58 in operating cash flow ($8.3M OCF vs $14.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-5.6x

Lifemd, Inc. earns $-5.6 in operating income for every $1 of interest expense (-$7.7M vs $1.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$194.1M

YoY+25.3%

5Y CAGR+39.1%

10Y CAGR+66.0%

Lifemd, Inc. generated $194.1M in revenue in fiscal year 2025. This represents an increase of 25.3% from the prior year.

EBITDA

-$6.7M

YoY+66.3%

Lifemd, Inc.'s EBITDA was -$6.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 66.3% from the prior year.

Net Income

$14.4M

YoY+167.0%

Lifemd, Inc. reported $14.4M in net income in fiscal year 2025. This represents an increase of 167.0% from the prior year.

EPS (Diluted)

$0.25

YoY+141.7%

Lifemd, Inc. earned $0.25 per diluted share (EPS) in fiscal year 2025. This represents an increase of 141.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$6.4M

YoY-60.1%

Lifemd, Inc. generated $6.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 60.1% from the prior year.

Cash & Debt

$36.8M

YoY+5.1%

5Y CAGR+32.0%

10Y CAGR+65.9%

Lifemd, Inc. held $36.8M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

47M

YoY+10.6%

5Y CAGR+14.9%

Lifemd, Inc. had 47M shares outstanding in fiscal year 2025. This represents an increase of 10.6% from the prior year.

Margins & Returns

Gross Margin

85.7%

YoY-0.4pp

5Y CAGR+9.5pp

10Y CAGR+6.0pp

Lifemd, Inc.'s gross margin was 85.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin

-4.0%

YoY+9.2pp

5Y CAGR+151.1pp

10Y CAGR+17.6pp

Lifemd, Inc.'s operating margin was -4.0% in fiscal year 2025, reflecting core business profitability. This is up 9.2 percentage points from the prior year.

Net Margin

7.4%

YoY+21.2pp

5Y CAGR+164.7pp

10Y CAGR+12.5pp

Lifemd, Inc.'s net profit margin was 7.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 21.2 percentage points from the prior year.

Return on Equity

62.0%

10Y CAGR+123.9pp

Lifemd, Inc.'s ROE was 62.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$270K

Lifemd, Inc. spent $270K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$1.9M

YoY+27.8%

Lifemd, Inc. invested $1.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 27.8% from the prior year.

LFMDP Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$194.1M+25.3%	$154.8M+1.5%	$152.5M+28.2%	$119.0M+28.2%	$92.9M+149.0%	$37.3M
Cost of Revenue	$27.7M+29.3%	$21.4M+13.4%	$18.9M+1.2%	$18.7M+3.7%	$18.0M+103.1%	$8.9M
Gross Profit	$166.3M+24.7%	$133.4M-0.2%	$133.6M+33.2%	$100.4M+34.0%	$74.9M+163.4%	$28.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$57.9M0.0%	$57.9M+12.1%	$51.7M+10.1%	$47.0M+18.8%	$39.5M-12.1%	$45.0M
Operating Income	-$7.7M+62.4%	-$20.4M-40.8%	-$14.5M+66.7%	-$43.4M+20.0%	-$54.3M+6.1%	-$57.8M
Interest Expense	$1.4M-37.4%	$2.2M-16.2%	$2.6M+103.5%	$1.3M-57.7%	$3.0M+81.1%	$1.7M
Income Tax	$46K-92.4%	$598K+39.7%	$428K+18.7%	$361K+4584.4%	$8K-93.7%	$123K
Net Income	$14.4M+167.0%	-$21.4M-3.9%	-$20.6M+54.8%	-$45.5M+25.2%	-$60.9M-3.8%	-$58.6M
EPS (Diluted)	$0.25+141.7%	$-0.60+14.3%	$-0.70+55.4%	$-1.57+31.4%	$-2.29+48.4%	$-4.44

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$7.1M-88.2%	$60.2M-4.0%	$62.7M-2.3%	$64.1M+850.7%	$6.7M-87.3%	$53.3M+5.2%	$50.7M+14.8%	$44.1M
Cost of Revenue	$4.2M-42.9%	$7.4M-0.3%	$7.4M-14.0%	$8.6M+27.1%	$6.8M+35.7%	$5.0M-0.2%	$5.0M+9.2%	$4.6M
Gross Profit	$2.8M-94.6%	$52.8M-4.5%	$55.2M-0.4%	$55.5M+98314.8%	-$56K-100.1%	$48.3M+5.7%	$45.6M+15.4%	$39.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6.7M-59.5%	$16.6M-5.6%	$17.6M+3.0%	$17.1M+184.0%	$6.0M-66.8%	$18.1M-2.2%	$18.5M+21.0%	$15.3M
Operating Income	-$6.2M-216.0%	-$2.0M-336.1%	-$452K-146.3%	$974K+124.8%	-$3.9M+1.7%	-$4.0M+36.6%	-$6.3M-2.2%	-$6.2M
Interest Expense	-$191K-172.7%	$262K-60.4%	$663K+5.9%	$626K+3.1%	$608K+8.8%	$559K+5.1%	$531K+11.3%	$478K
Income Tax	N/A	$169K	N/A	N/A	N/A	$233K	N/A	N/A
Net Income	$20.0M+624.5%	-$3.8M-135.0%	-$1.6M-781.3%	-$184K+94.1%	-$3.1M+33.3%	-$4.7M+32.3%	-$6.9M-1.6%	-$6.8M
EPS (Diluted)	N/A	$-0.10-100.0%	$-0.05-150.0%	$-0.02	N/A	$-0.13+31.6%	$-0.190.0%	$-0.19

LFMDP Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$70.4M-7.5%	$76.1M+30.1%	$58.5M+127.9%	$25.7M-48.6%	$49.9M+272.5%	$13.4M
Current Assets	$51.8M-1.0%	$52.4M+22.9%	$42.6M+276.7%	$11.3M-74.8%	$44.9M+261.9%	$12.4M
Cash & Equivalents	$36.8M+5.1%	$35.0M+5.6%	$33.1M+737.3%	$4.0M-90.4%	$41.3M+350.2%	$9.2M
Inventory	$2.8M-0.9%	$2.8M+1.4%	$2.8M-25.5%	$3.7M+129.1%	$1.6M+27.9%	$1.3M
Accounts Receivable	$9.3M-11.0%	$10.5M+66.9%	$6.3M+121.0%	$2.8M+189.2%	$980K-1.8%	$998K
Goodwill	N/A	N/A	N/A	$8.0M	$0	N/A
Total Liabilities	$47.3M-43.5%	$83.7M+58.1%	$52.9M+60.5%	$33.0M+36.8%	$24.1M+69.5%	$14.2M
Current Liabilities	$41.6M-38.3%	$67.4M+93.8%	$34.8M+10.9%	$31.4M+37.5%	$22.8M+63.8%	$13.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$23.2M+354.9%	-$9.1M-359.1%	$3.5M+130.8%	-$11.4M-150.1%	$22.7M+1087.9%	-$2.3M
Retained Earnings	-$228.6M+4.7%	-$239.9M-11.9%	-$214.3M-12.4%	-$190.6M-34.3%	-$141.9M-77.1%	-$80.2M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$70.4M+6.7%	$66.0M-10.3%	$73.6M-0.1%	$73.6M-3.3%	$76.1M+4.9%	$72.6M+13.7%	$63.8M+3.8%	$61.5M
Current Assets	$51.8M+26.2%	$41.1M-16.2%	$49.0M-1.9%	$50.0M-4.6%	$52.4M+7.6%	$48.7M+8.0%	$45.1M+1.5%	$44.4M
Cash & Equivalents	$36.8M+54.7%	$23.8M-34.3%	$36.2M+5.3%	$34.4M-1.7%	$35.0M-6.9%	$37.6M+5.3%	$35.7M+1.7%	$35.1M
Inventory	$2.8M-19.2%	$3.4M+5.6%	$3.3M+9.6%	$3.0M+6.1%	$2.8M+5.7%	$2.6M+28.4%	$2.1M-13.2%	$2.4M
Accounts Receivable	$9.3M+0.7%	$9.2M+26.1%	$7.3M-28.1%	$10.2M-2.5%	$10.5M+72.8%	$6.0M+6.7%	$5.7M+6.2%	$5.3M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$47.3M-24.5%	$62.6M-14.4%	$73.2M-1.1%	$74.0M-11.5%	$83.7M+6.5%	$78.5M+19.2%	$65.9M+9.5%	$60.2M
Current Liabilities	$41.6M-26.6%	$56.7M-10.8%	$63.5M+4.3%	$60.9M-9.6%	$67.4M+14.3%	$59.0M+14.1%	$51.6M+15.6%	$44.7M
Long-Term Debt	N/A	N/A	$15.9M	N/A	N/A	N/A	N/A	N/A
Total Equity	$23.2M+1661.8%	$1.3M+173.7%	-$1.8M+23.5%	-$2.3M+74.4%	-$9.1M-17.7%	-$7.7M-83.5%	-$4.2M-397.6%	-$845K
Retained Earnings	-$228.6M+7.7%	-$247.8M-3.9%	-$238.5M-1.2%	-$235.6M+1.8%	-$239.9M-1.9%	-$235.4M-2.6%	-$229.5M-3.4%	-$221.8M

LFMDP Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$8.3M-52.7%	$17.5M+98.6%	$8.8M+138.5%	-$22.9M+30.7%	-$33.1M-172.7%	-$12.1M
Capital Expenditures	$1.9M+27.8%	$1.5M+618.0%	$204K-44.4%	$367K+48.2%	$247K	N/A
Free Cash Flow	$6.4M-60.1%	$16.0M+86.3%	$8.6M+137.0%	-$23.3M+30.1%	-$33.3M	N/A
Investing Cash Flow	$6.9M+159.9%	-$11.5M-32.1%	-$8.7M+37.2%	-$13.9M-308.7%	-$3.4M-326.3%	-$798K
Financing Cash Flow	-$13.4M-225.5%	-$4.1M-114.2%	$29.1M+5609.4%	-$528K-100.8%	$68.6M+226.8%	$21.0M
Dividends Paid	$3.1M0.0%	$3.1M0.0%	$3.1M0.0%	$3.1M+256.4%	$871K	N/A
Share Buybacks	$270K	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$3.3M-2129.6%	-$147K-101.7%	$8.6M+181.6%	$3.1M+185.9%	$1.1M-84.0%	$6.7M+47.5%	$4.5M-12.7%	$5.2M
Capital Expenditures	$155K-80.5%	$797K+0.2%	$796K+551.1%	$122K-38.2%	$198K-55.8%	$448K-30.3%	$642K+265.7%	$176K
Free Cash Flow	-$3.4M-263.8%	-$944K-112.0%	$7.8M+166.2%	$2.9M+236.6%	$875K-86.0%	$6.3M+60.4%	$3.9M-22.5%	$5.0M
Investing Cash Flow	$17.1M+574.9%	-$3.6M+2.8%	-$3.7M-29.0%	-$2.9M-5.4%	-$2.7M+22.1%	-$3.5M-11.5%	-$3.1M-43.0%	-$2.2M
Financing Cash Flow	-$789K+90.9%	-$8.7M-180.2%	-$3.1M-282.1%	-$813K+13.1%	-$935K+29.2%	-$1.3M-62.0%	-$815K+22.2%	-$1.0M
Dividends Paid	$777K0.0%	$777K0.0%	$777K0.0%	$777K0.0%	$777K0.0%	$777K0.0%	$777K0.0%	$777K
Share Buybacks	N/A	$270K	N/A	N/A	N/A	N/A	N/A	N/A

LFMDP Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	85.7%-0.4pp	86.2%-1.5pp	87.6%+3.3pp	84.3%+3.7pp	80.6%+4.4pp	76.2%
Operating Margin	-4.0%+9.2pp	-13.2%-3.7pp	-9.5%+27.0pp	-36.5%+22.0pp	-58.5%+96.6pp	-155.0%
Net Margin	7.4%+21.2pp	-13.8%-0.3pp	-13.5%+24.8pp	-38.3%+27.3pp	-65.6%+91.7pp	-157.3%
Return on Equity	62.0%	N/A	-587.6%	N/A	-267.8%	N/A
Return on Assets	20.4%+48.5pp	-28.1%+7.1pp	-35.2%+142.2pp	-177.4%-55.4pp	-122.0%+315.6pp	-437.6%
Current Ratio	1.25+0.5	0.78-0.4	1.22+0.9	0.36-1.6	1.97+1.1	0.89
Debt-to-Equity	2.04+11.3	-9.21-24.3	15.10+18.0	-2.89-4.0	1.06+7.2	-6.18
FCF Margin	3.3%-7.1pp	10.4%+4.7pp	5.7%+25.2pp	-19.6%+16.3pp	-35.9%	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	40.2%-47.5pp	87.7%-0.4pp	88.1%+1.6pp	86.5%+87.4pp	-0.8%-91.4pp	90.6%+0.5pp	90.1%+0.5pp	89.6%
Operating Margin	-87.9%-84.6pp	-3.3%-2.6pp	-0.7%-2.2pp	1.5%+59.8pp	-58.2%-50.7pp	-7.5%+5.0pp	-12.4%+1.5pp	-14.0%
Net Margin	282.0%+288.3pp	-6.3%-3.7pp	-2.6%-2.3pp	-0.3%+45.8pp	-46.1%-37.3pp	-8.7%+4.8pp	-13.6%+1.8pp	-15.3%
Return on Equity	86.2%+375.8pp	-289.6%	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	28.3%+34.1pp	-5.8%-3.6pp	-2.2%-1.9pp	-0.3%+3.8pp	-4.1%+2.3pp	-6.4%+4.4pp	-10.8%+0.2pp	-11.0%
Current Ratio	1.25+0.5	0.73-0.0	0.77-0.0	0.82+0.0	0.78-0.0	0.83-0.0	0.87-0.1	0.99
Debt-to-Equity	2.04-45.6	47.64+56.6	-8.92+22.9	-31.78-22.6	-9.21+1.0	-10.17+5.5	-15.66+55.5	-71.17
FCF Margin	-48.5%-47.0pp	-1.6%-14.1pp	12.5%+7.9pp	4.6%-8.4pp	13.0%+1.2pp	11.7%+4.0pp	7.7%-3.7pp	11.4%

Similar Companies

CARECLOUD INC CCLDO

ACLARION INC ACONW

VSee Health, Inc. VSEE

$10.8M

OneMedNet ONMDW

Mangoceuticals, Inc. MGRX

$5.9M

Frequently Asked Questions

What is Lifemd, Inc.'s annual revenue?

Lifemd, Inc. (LFMDP) reported $194.1M in total revenue for fiscal year 2025. This represents a 25.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lifemd, Inc.'s revenue growing?

Lifemd, Inc. (LFMDP) revenue grew by 25.3% year-over-year, from $154.8M to $194.1M in fiscal year 2025.

Is Lifemd, Inc. profitable?

Yes, Lifemd, Inc. (LFMDP) reported a net income of $14.4M in fiscal year 2025, with a net profit margin of 7.4%.

What is Lifemd, Inc.'s EBITDA?

Lifemd, Inc. (LFMDP) had EBITDA of -$6.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Lifemd, Inc.'s gross margin?

Lifemd, Inc. (LFMDP) had a gross margin of 85.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lifemd, Inc.'s operating margin?

Lifemd, Inc. (LFMDP) had an operating margin of -4.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Lifemd, Inc.'s net profit margin?

Lifemd, Inc. (LFMDP) had a net profit margin of 7.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Lifemd, Inc.'s return on equity (ROE)?

Lifemd, Inc. (LFMDP) has a return on equity of 62.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lifemd, Inc.'s free cash flow?

Lifemd, Inc. (LFMDP) generated $6.4M in free cash flow during fiscal year 2025. This represents a -60.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lifemd, Inc.'s operating cash flow?

Lifemd, Inc. (LFMDP) generated $8.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Lifemd, Inc.'s total assets?

Lifemd, Inc. (LFMDP) had $70.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lifemd, Inc.'s capital expenditures?

Lifemd, Inc. (LFMDP) invested $1.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Lifemd, Inc. buy back shares?

Yes, Lifemd, Inc. (LFMDP) spent $270K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Lifemd, Inc. have outstanding?

Lifemd, Inc. (LFMDP) had 47M shares outstanding as of fiscal year 2025.

What is Lifemd, Inc.'s current ratio?

Lifemd, Inc. (LFMDP) had a current ratio of 1.25 as of fiscal year 2025, which is considered adequate.

What is Lifemd, Inc.'s debt-to-equity ratio?

Lifemd, Inc. (LFMDP) had a debt-to-equity ratio of 2.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lifemd, Inc.'s return on assets (ROA)?

Lifemd, Inc. (LFMDP) had a return on assets of 20.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lifemd, Inc.'s Piotroski F-Score?

Lifemd, Inc. (LFMDP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lifemd, Inc.'s earnings high quality?

Lifemd, Inc. (LFMDP) has an earnings quality ratio of 0.58x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Lifemd, Inc. cover its interest payments?

Lifemd, Inc. (LFMDP) has an interest coverage ratio of -5.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Lifemd, Inc.?

Lifemd, Inc. (LFMDP) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.